ロード中...
Striving for optimal bronchodilation: focus on olodaterol
β(2)-agonists were introduced in the 1940s as bronchodilators to be used in obstructive respiratory diseases. Long-acting β(2)-agonists have been a mainstay of bronchodilating treatment for decades. Recently, agents extending their effect to 24 hours and thus allowing the once-daily administration w...
保存先:
| 出版年: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4780202/ https://ncbi.nlm.nih.gov/pubmed/27042036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S96070 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|